[Cost-effectiveness of anti-tumor associated antigen autoantibody screening for hepatocellular carcinoma in the population with chronic hepatitis B-related cirrhosis].
Zhonghua Yi Xue Za Zhi
; 101(32): 2544-2551, 2021 Aug 24.
Article
en Zh
| MEDLINE
| ID: mdl-34407581
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Carcinoma Hepatocelular
/
Hepatitis B Crónica
/
Neoplasias Hepáticas
Tipo de estudio:
Diagnostic_studies
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Adult
/
Humans
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Año:
2021
Tipo del documento:
Article
País de afiliación:
China